PharmaTher Holdings Ltd. (CNQ: PHRM.CN) AI-Powered Stock Analysis
See how PharmaTher Holdings Ltd. scores across key metrics like financial growth, valuation, and market position on the CNQ, using AI-driven evaluation.
PHRM.CN●CNQ
HealthcareBiotechnology
$0.07
$0.005(8.33%)
Canadian Market opens in 16h 37m
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerPharmaTher Holdings Ltd. (CNQ: PHRM.CN) Stock Overall Grade
PharmaTher Holdings Ltd.'s grade for its CNQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to PharmaTher Holdings Ltd.'s overall CNQ stock rating.
Forecast
CScore
49/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
59/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100PharmaTher Holdings Ltd. (CNQ: PHRM.CN) AI-Powered Stock Analysis
On the CNQ, PHRM.CN demonstrates Normal performance with an overall Forecast Score of 49/100 (C), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (59/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the CNQ-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(CNQ: PHRM.CN) Component Analysis Explained
Understand the key factors behind each PharmaTher Holdings Ltd. (CNQ: PHRM.CN) stock grade, including financials, comparisons, and forecasts.